Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited)

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Arbuz Group LLP ("Arbuz")
ReKassa
Total equity attributable to the shareholders'
Total equity attributable to the shareholders'
Cumulative Effect, Period of Adoption, Adjustment
Total equity attributable to the shareholders'
Arbuz Group LLP ("Arbuz")
Common Stock
Additional paid in capital
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Arbuz Group LLP ("Arbuz")
Accumulated other comprehensive loss
Non- controlling interest
Non- controlling interest
Arbuz Group LLP ("Arbuz")
Non- controlling interest
ReKassa
Beginning balance (in shares) at Mar. 31, 2023               59,659,191,000                
Equity, beginning of period at Mar. 31, 2023 $ 770,736 $ (22,772)     $ 777,285 $ (22,772)   $ 59 $ 164,162 $ 647,064 $ (22,772)   $ (34,000) $ (6,549)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock based compensation 2,264       2,264       2,264              
Disposal of FF Ukraine 0       (6,549)         (6,549)       6,549    
Purchase of subsidiary shares     $ 9,097 $ 256     $ 5,457         $ 5,457     $ 3,640 $ 256
Foreign currency translation adjustments, net of tax effect (31,693)       (31,693)               (31,693)      
Other comprehensive income 3,143       3,143               3,143      
Net income/(loss) 183,400       183,949         183,949       (549)    
Ending balance (in shares) at Sep. 30, 2023               59,659,191,000                
Equity, end of period at Sep. 30, 2023 914,431       911,084     $ 59 166,426 807,149     (62,550) 3,347    
Beginning balance (in shares) at Jun. 30, 2023               59,659,191,000                
Equity, beginning of period at Jun. 30, 2023 825,736       822,277     $ 59 165,395 691,302     (34,479) 3,459    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock based compensation 1,031       1,031       1,031              
Purchase of subsidiary shares       $ 256                       $ 256
Foreign currency translation adjustments, net of tax effect (29,933)       (29,933)               (29,933)      
Other comprehensive income 1,862       1,862               1,862      
Net income/(loss) 115,479       115,847         115,847       (368)    
Ending balance (in shares) at Sep. 30, 2023               59,659,191,000                
Equity, end of period at Sep. 30, 2023 $ 914,431       911,084     $ 59 166,426 807,149     (62,550) 3,347    
Beginning balance (in shares) at Mar. 31, 2024 60,321,813             60,321,813                
Equity, beginning of period at Mar. 31, 2024 $ 1,166,958       1,163,650     $ 60 183,788 998,740     (18,938) 3,308    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Delivered stock based compensation from previous quarter (in shares)               215,878                
Delivered stock based compensation from previous quarter 3,092       3,092       3,092              
Forfeited stock based compensation (in shares)               (310,700)                
Forfeited stock based compensation 0                              
Undelivered stock based compensation (in shares)               (12,816)                
Undelivered stock based compensation (302)       (302)       (302)              
Stock based compensation (in shares)               343,626                
Stock based compensation 22,672       22,672     $ 1 22,671              
Foreign currency translation adjustments, net of tax effect (85,778)       (85,778)               (85,778)      
Other comprehensive income 7,847       7,847               7,847      
Net income/(loss) $ 148,747       149,058         149,058       (311)    
Ending balance (in shares) at Sep. 30, 2024 60,557,801             60,557,801                
Equity, end of period at Sep. 30, 2024 $ 1,263,236       1,260,239     $ 61 209,249 1,147,798     (96,869) 2,997    
Beginning balance (in shares) at Jun. 30, 2024               60,721,010                
Equity, beginning of period at Jun. 30, 2024 1,152,179       1,149,012     $ 60 197,205 1,033,140     (81,393) 3,167    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Delivered stock based compensation from previous quarter (in shares)               3,648                
Delivered stock based compensation from previous quarter 290       290       290              
Forfeited stock based compensation (in shares)               (310,700)                
Forfeited stock based compensation 0                              
Undelivered stock based compensation (in shares)               (12,816)                
Undelivered stock based compensation $ (302)       (302)       (302)              
Stock based compensation (in shares) 156,659             156,659                
Stock based compensation $ 12,057       12,057     $ 1 12,056              
Foreign currency translation adjustments, net of tax effect (19,967)       (19,967)               (19,967)      
Other comprehensive income 4,491       4,491               4,491      
Net income/(loss) $ 114,488       114,658         114,658       (170)    
Ending balance (in shares) at Sep. 30, 2024 60,557,801             60,557,801                
Equity, end of period at Sep. 30, 2024 $ 1,263,236       $ 1,260,239     $ 61 $ 209,249 $ 1,147,798     $ (96,869) $ 2,997